Amgen, Sanofi to Fight Over Enhanced Damages in Blockbuster Infringement Row

, Delaware Law Weekly


A Delaware federal judge has allowed Amgen Inc. to pursue enhanced damages in its patent infringement dispute with a rival drugmaker, the latest development to a case with billions of dollars on the line.

This premium content is reserved for Delaware Law Weekly subscribers.

Continue reading by getting started with a subscription.

Already a subscriber? Log in now

What's being said

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article #1202784218407

Thank you!

This article's comments will be reviewed.